Posts

Showing posts with the label Lyme Disease Treatment

Lyme Disease Treatment Market | Trends,Size, Growth, Share, COVID-19 Impact ...

Image
  Disease can be an infectious disease, caused due to the bacterium – Borrelia burgdorferi, which is transmitted to humans through bites of infected adult black-legged ticks. Most human infections are due to bites of nymphs (immature tick). Ticks can attach to any part of the human body and can transmit the infection, if attached to the host body for 36 to 48 hours. Blacklegged ticks are accountable for spreading Lyme disease in the northeastern, mid-Atlantic, and north-central aspects of the U.S. However, western black-legged ticks spread Lyme disease in the regions across the Pacific Coast. These regions are thus, anticipated to witness rapid growth of industry for Lyme disease treatment in the near future.   The major players operating in the Lyme Disease Treatment Market include Lupin Ltd, Mylan N.V., Sun Pharmaceuticals Industries Ltd., Pfizer Inc., G&W Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, GlaxoSmithKline plc., and Hospira Inc.   A...